Forbes quoted Mireille Jacobson of the USC Leonard Davis School on how pharmaceutical insurance coverage decisions are made based on drug efficacy.
Home » Some Say A Nonprofit Research Group Unfairly Influences Drug Prices (Forbes)
Related Posts
In the News
March 20, 2023
AI May Predict Alzheimer’s Through Brain Age (National Science Foundation News)
In the News
March 20, 2023